Natural analogue peptides of an HIV-1 GP120 T-helper epitope antagonize response of GP120-specific human CD4 T-cell clones

J Acquir Immune Defic Syndr. 2000 Jan 1;23(1):1-7. doi: 10.1097/00126334-200001010-00001.

Abstract

Neutralizing antibodies and specific cytotoxic T lymphocytes (CTL) may contribute to controlling viral spread, and ideally, to virus clearance in HIV infection. Both effector mechanisms depend on specific CD4 T-helper (Th) cells. Nevertheless, HIV hypervariability facilitates appearance of escape mutants for antibodies and for CTL responses. Here we also show that natural mutations (i.e., from sequences of different HIV strains) in an immunodominant Th epitope recognized by human CD4 clones specific for the envelope glycoprotein gp120 escape CD4 T-cell recognition. Furthermore, several natural analogue peptides exert an antagonistic function by inhibiting proliferative response of T cells specific to gp120 with a wild-type sequence. If similar events occur in vivo, they may represent an additional escape mechanism for HIV. In fact, antagonism for CD4 Th response may occur during superinfection with a different strain, or with the appearance of a variant carrying a mutated antagonistic sequence. In both cases, impaired Th cell function could lead to reduced immune control of HIV infection by interfering with CTL and antibody response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids / immunology
  • CD4-Positive T-Lymphocytes / drug effects*
  • Clone Cells
  • Epitopes
  • HIV Envelope Protein gp120 / genetics
  • HIV Envelope Protein gp120 / immunology*
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • Humans
  • Immunodominant Epitopes
  • Mutation
  • Oligopeptides / immunology
  • Oligopeptides / pharmacology*
  • T-Lymphocytes, Helper-Inducer / immunology*

Substances

  • Amino Acids
  • Epitopes
  • HIV Envelope Protein gp120
  • Immunodominant Epitopes
  • Oligopeptides